The overarching outcome of the MEng program is that graduates develop impactful careers in industry. To accomplish this goal, KGI faculty developed several learning outcomes for the program, along with identifying key skills that all students should possess when they graduate.

Learning Outcomes

  • Students use bioprocessing principles to design processes necessary to translate basic life science discoveries into commercial products, which benefit society.
  • Students contribute effectively in an interdisciplinary team to work complex process engineering challenges associated with biomanufacturing of biologics.
  • Students understand the IP, regulatory, business, and marketing functions of the biopharmaceutical industry.
  • Students communicate effectively in an external environment composed of scientists, engineers and business professionals.
  • Students adhere to ethical principles in research, development, regulatory and quality issues inherent in the biopharmaceutical and related industries.

Key Skills:

  • 21st Century Biologics Process and Product Research, Design and Development
  • Chemistry, Manufacturing & Control (CMC) Regulatory Compliance and Quality Control
  • Technology Development
  • Biomanufacturing platforms
  • Process Validation
  • Supply Chain Management
  • Quality-by-Design
  • Continuous Product and Process Improvement
  • Process Economics and Cost Analysis
  • Leadership, Project Management and Professionalism
  • Ethics
  • Change Advocacy

**WASC Approved